N-desmethylimatinib,
N-Desmethyl Imatinib,
404844-02-6,
N-Desmethylimatinib,
Norimatinib,
Imatinib metabolite N-Desmethyl Imatinib,
UNII-6GOH0N63QD,
CGP-74588,
Desmethyl Imatinib (Desmethyl Gleevec),
6GOH0N63QD,
n-desmethyl imatinib;n-{4-methyl-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)phenyl}-4-(piperazin-1-ylmethyl)benzamide,
CHEMBL2386594,
N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-benzamide,
N Desmethyl imatinib,
N-Desmethyl Gleevec,
CGP 74588,
STI-50900,
ACMC-20em6q,
n-Demethylated piperazine,
SCHEMBL846536,
CHEMBL3040018,
C28H29N7O,
CTK4I3160,
DTXSID80193500,
BQQYXPHRXIZMDM-UHFFFAOYSA-N,
CGP74588,
EBD32458,
HY-G0017,
3920AH,
BDBM50434582,
MFCD07369291,
ZINC21981222,
AKOS024573735,
ACN-026573,
STI 509-00,
TRA0014372,
KS-0000007K,
N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-(piperazin-1-ylmethyl)benzamide,
NCGC00485941-01,
AC-23925,
BC228334,
Benzamide, N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-4-(1-piperazinylmethyl)-,
n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(piperazin-1-ylmethyl)-benzamide,
SC-47707,
RT-014408,
FT-0666167,
Benzamide,N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-(1-piperazinylmethyl)-,
N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(piperazin-1-ylmethyl)benzamide,
N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-(piperazin-1-ylmethyl)benzamide,
N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(piperazin-1-yl)methyl]benzamide,
N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide,
n-desmethyl imatinibn-{4-methyl-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)phenyl}-4-(piperazin-1-ylmethyl)benzamide,
Imatinib Impurity,
Imatinib N-Desmethyl Impurity,
STI-509-00,
CID9869737,
CS-4156,
CS-O-05955,
N-Desmethyl imatinib, 98% - 100MG 100mg,
87233-54-3,